Abstract 13541: Six-Month Blood Pressure Trajectories and Wearable Correlates of Clinically Meaningful Blood Pressure Reduction in 20,003 Adults with Elevated Blood Pressure and Hypertension
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.13541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Christian Cheung und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Hypertension is a leading risk factor for cardiovascular disease. Digital health platforms have emerged as effective for hypertension management but often require dedicated clinical infrastructure. Consumer wearable platforms, which are widely adopted for everyday health monitoring and increasingly support blood pressure (BP) tracking, provide a scalable alternative for BP self-management which can be paired with continuous physiological monitoring. Hypotheses: We aimed to: i) characterize 6-month BP trajectories in a large free-living cohort of wearable device users with above-goal BP, and ii) identify wearable biometric and engagement factors associated with BP improvement at both the daily-level and over 6 months. We hypothesized that users would experience clinically meaningful reductions in BP over 6 months and that biometric and engagement metrics would be associated with these improvements.
Methods
We retrospectively identified 20,003 adults aged 18-79 years (M/F: 18,382/1,621) with cuff-measured elevated BP (n=5,163), stage 1 hypertension (n=10,269), or stage 2 hypertension (n=4,571) who engaged with the wearable platform over 6 months. Change in BP over 6 months was estimated using linear mixed effects models (α=0.005). Mixed-effects models quantified within-person associations between day-level BP and concurrently measured wearable-derived biometrics across 132,843 BP readings collected over the 6-month period. At the participant level, logistic regression models identified 6-month biometric and engagement-based correlates of clinically meaningful BP reduction (≥5mmHg).
Results
Systolic BP was reduced in all baseline strata at 6 months (Elevated: -2.48mmHg [95% CI: -2.77, -2.19]; Stage 1: -3.67mmHg [-3.88, -3.47]; Stage 2: -11.62mmHg [-11.92, -11.31]; p
Zitieren
APA
Cheung, C., Cohen, J., Curran, D., Parola, L., Fielding, F., Chapman, C., Hippel, W. V., Holmes, K., & Grosicki, G. (2026). Abstract 13541: Six-Month Blood Pressure Trajectories and Wearable Correlates of Clinically Meaningful Blood Pressure Reduction in 20,003 Adults with Elevated Blood Pressure and Hypertension. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.13541
Vancouver
Cheung C, Cohen J, Curran D, Parola L, Fielding F, Chapman C, et al. Abstract 13541: Six-Month Blood Pressure Trajectories and Wearable Correlates of Clinically Meaningful Blood Pressure Reduction in 20,003 Adults with Elevated Blood Pressure and Hypertension. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.13541
BibTeX
@article{Cheung2026,
author = {Cheung, Christian and Cohen, Jenna and Curran, Dylan and Parola, Lauren and Fielding, Finn and Chapman, Christopher and Hippel, William von and Holmes, Kristen and Grosicki, Greg},
title = {Abstract 13541: Six-Month Blood Pressure Trajectories and Wearable Correlates of Clinically Meaningful Blood Pressure Reduction in 20,003 Adults with Elevated Blood Pressure and Hypertension},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.13541}
}
EUVIMED